Anders Björklund
Neuroscience · Regenerative Medicine
Sweden
Overview
World-renowned neuroscientist and pioneer of cell transplantation therapy for Parkinson's disease.
Biography
Executive Summary
Dr. Anders Björklund is a titan of modern neuroscience and a pioneer in the field of Restorative Neurology. A Professor of Histology at Lund University, Sweden, he is world-renowned for his groundbreaking work on cell transplantation and gene therapy for Parkinson's Disease. His research provided the first proof-of-concept that damaged neurons in the mammalian brain can be regenerated and reconnected, fundamentally changing the dogma of brain plasticity.
Early Life and Education
Born in 1945 in Söderhamn, Sweden, Dr. Björklund received his MD in 1969 and PhD in 1970 from Lund University. He was part of the golden generation of Swedish neuroscientists who developed the Falck-Hillarp fluorescence method, allowing the comprehensive mapping of monoamine systems in the brain.
Scientific Contributions
- Dopamine System Mapping: In the 1970s, he co-authored the definitive atlases of dopamine and serotonin pathways in the brain, which remain standard references today.
- Cell Transplantation: In 1979, he performed the first successful transplantation of fetal dopamine neurons into the brains of rats with Parkinson-like symptoms, restoring motor function. This work laid the foundation for human clinical trials started in Lund in 1987.
- Gene Therapy: His team demonstrated the neuroprotective effects of Glial Cell Line-Derived Neurotrophic Factor (GDNF), leading to clinical trials delivering GDNF genes to Parkinson's patients.
Awards and Recognition
- The Brain Prize (2011): Shared with Winfried Denk and Ann Graybiel for his work on brain circuits.
- Signe and Ane Gyllenberg Foundation Prize (2023)
- Member of the Royal Swedish Academy of Sciences and the National Academy of Sciences (USA).
Legacy
Dr. Björklund's work launched the field of neural grafting. He continues to lead the Wallenberg Neuroscience Center, pushing the boundaries of stem cell therapy. His h-index of over 170 reflects a lifetime of high-impact research that consistently opens new avenues for treating neurodegenerative diseases.
Affiliations & Institutions
Research Impact
Published In
Key Publications
Identification of proliferating neural progenitors in the adult human hippocampus.
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease.
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.
Effect of Isocaloric Meals on Postprandial Glycemic and Metabolic Markers in Type 1 Diabetes-A Randomized Crossover Trial.
Author Correction: A comprehensive human embryo reference tool using single-cell RNA-sequencing data.
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Media Archive